Advertisement
UK markets open in 5 hours 59 minutes

  • NIKKEI 225

    40,911.55
    -2.10 (-0.01%)
     

  • HANG SENG

    18,028.28
    +49.71 (+0.28%)
     

  • CRUDE OIL

    84.01
    +0.13 (+0.15%)
     

  • GOLD FUTURES

    2,369.40
    0.00 (0.00%)
     

  • DOW

    39,308.00
    -23.90 (-0.06%)
     

  • Bitcoin GBP

    44,925.41
    -2,362.30 (-5.00%)
     

  • CMC Crypto 200

    1,188.33
    -72.85 (-5.77%)
     

  • NASDAQ Composite

    18,188.30
    +159.54 (+0.88%)
     

  • UK FTSE All Share

    4,497.97
    +34.88 (+0.78%)
     
Money:

What a Labour government needs to do for pensions and work in the first 100 days

The next government should hit the ground running — here is what should be on the to-do list

EU antitrust regulators set Nov. 28 deadline for Novozymes, Chr. Hansen deal

Reuters
·1-min read
FILE PHOTO: A worker for the Danish biopharmaceutical company Novozymes stands next to fermentation vates for producing enzymes at a factory in Beijing

BRUSSELS (Reuters) - EU antitrust regulators will decide by Nov. 28 whether to clear Danish food ingredients and enzymes makers Novozymes and Chr. Hansen's tie-up, according to a European Commission filing.

The companies, which announced the deal in December last year, sought EU approval for the merger last Friday.

The EU competition enforcer can decide to clear the deal with or without remedies after its preliminary review or it can open a four-month long investigation if it has serious concerns.

Chr. Hansen focuses on enzymes and microbials for the food sector, while Novozymes' largest business areas include enzymes for household products, food and beverages and biofuels.

(Reporting by Foo Yun Chee; editing by Barbara Lewis)